Global Extracorporeal Membrane Oxygenation Machines Market 2020–2024 | Evolving Opportunities with ALung Technologies Inc. and Eurosets Srl | Technavio
The extracorporeal membrane oxygenation machines market is poised to grow by USD 67.79 million during 2020–2024, progressing at a CAGR of almost 5% during the forecast period. Request free sample pages
Read the 155-page report with TOC on “Extracorporeal Membrane Oxygenation Machines Market Analysis Report by Modality (Veno-venous and arterio-venous, and Veno-arterial), Geographic Landscape (Asia, Europe, North America, and ROW), and the Segment Forecasts, 2020–2024”.
The market is driven by the increasing incidences of respiratory failures. In addition, the technological advances are anticipated to boost the growth of the extracorporeal membrane oxygenation machines market.
Respiratory diseases such as COPD, ARDS, and pulmonary embolism affect a large number of people across the world. The rising prevalence of these diseases can be attributed to factors such as respiratory infections, smoking, and air pollution. Similarly, the prevalence of CVDs and other heart diseases such as ischemic heart disease, coronary heart disease, and myocardial infarctions has significantly increased over recent years. These factors have increased the number of emergency department visits, which has necessitated the need for immediate treatment. Extracorporeal membrane oxygenation machines are majorly used for reducing the chances of cardiac failure in people with CVDs. They are also used by healthcare professionals to help patients at the risk of sudden respiratory failure. Therefore, the increasing incidences of respiratory and heart failures are expected to fuel market growth during the forecast period.
Buy 1 Technavio report and get the second for 50% off. Buy 2 Technavio reports and get the third for free.
View market snapshot before purchasing
Major Five Extracorporeal Membrane Oxygenation Machines Companies:
ALung Technologies Inc.
ALung Technologies Inc. operates the business through the Respiratory segment. The company offers advanced medical devices to treat respiratory failure. Hemolung RAS is one of the key offerings of the company.
Eurosets Srl
Eurosets Srl operates the business across segments such as Cardiopulmonary, Chest drainage, ECLS, OEM components, Surgical support, and Wound management. The company offers a wide range of extracorporeal membrane oxygenation machines. ECMO ADULT 14 days is one of the key offerings of the company.
Fresenius Medical Care AG & Co. KGaA
Fresenius Medical Care AG & Co. KGaA operates the business across segments such as Health care services and Health care products. ILA ACTIVVE XLUNG KIT is one of the key offerings of the company.
Getinge AB
Getinge AB operates the business across segments such as Acute Care Therapies, Surgical Workflows, and Life Science. PLS System is one of the key offerings of the company.
LivaNova PLC
LivaNova PLC operates the business across segments such as Cardiovascular and Neuromodulation. LifeSPARC is one of the key offerings of the company.
Extracorporeal Membrane Oxygenation Machines Modality Outlook (Revenue, USD Million, 2020–2024)
- Veno-venous and arterio-venous
- Veno-arterial
Extracorporeal Membrane Oxygenation Machines Market Geographic Outlook (Revenue, USD Million, 2020–2024)
- Asia — size and forecast 2019–2024
- Europe — size and forecast 2019–2024
- North America — size and forecast 2019–2024
- ROW — size and forecast 2019–2024
- Key leading countries
Technavio’s sample reports are free of charge and contain multiple sections of the report, such as the market size and forecast, drivers, challenges, trends, and more. Request a free sample report
